Catalysts for $ABBV
477 tracked
Sep 17, 2015
approval
VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
CARIPRAZINE HYDROCHLORIDE
→
Sep 17, 2015
approval
VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
CARIPRAZINE HYDROCHLORIDE
→
Sep 9, 2015
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Aug 24, 2015
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Aug 17, 2015
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Aug 13, 2015
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Jun 25, 2015
approval
ESCITALOPRAM OXALATE — FDA approval
AbbVie Inc.
→
May 22, 2015
approval
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
Mar 20, 2015
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 13, 2015
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 13, 2015
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 13, 2015
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Jan 29, 2015
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Jan 9, 2015
approval
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
Jan 7, 2015
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Jan 7, 2015
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Jan 7, 2015
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Jan 5, 2015
approval
LINZESS (LINACLOTIDE) — FDA approval
linaclotide
→
Dec 24, 2014
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Dec 13, 2014
approval
ESCITALOPRAM OXALATE — FDA approval
AbbVie Inc.
→
Dec 11, 2014
approval
LINZESS (LINACLOTIDE) — FDA approval
linaclotide
→
Nov 20, 2014
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 20, 2014
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 20, 2014
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 6, 2014
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Nov 4, 2014
approval
ESCITALOPRAM OXALATE — FDA approval
AbbVie Inc.
→
Oct 29, 2014
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Sep 30, 2014
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Sep 26, 2014
approval
OZURDEX (DEXAMETHASONE) — FDA approval
dexamethasone LA
→
Sep 23, 2014
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→